Hydrochloric Acid

Hydrochloric Acid

SCHEMBL555933

Cl.Cl.NC1CCNC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3403057 1.00
Hydrochloric Acid SCHEMBL3398662 1.00
Hydrochloric Acid SCHEMBL30639437 1.00 SLC6A1 (0.36)
Hydrochloric Acid SCHEMBL641358 1.00
Hydrochloric Acid SCHEMBL28683389 1.00
Hydrochloric Acid SCHEMBL4717529 1.00
Hydrochloric Acid SCHEMBL1266793 1.00
Methane SCHEMBL28288633 0.97
SCHEMBL203460 0.97
SCHEMBL336177 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114369052-B Synthesis method of 3-aminopyrrolidine dihydrochloride 赤峰万泽药业股份有限公司 2024-10-15 CN claimed
CN-114369052-A Synthetic method of 3-aminopyrrolidine dihydrochloride 赤峰万泽药业股份有限公司 2022-04-19 CN claimed
CN-114369092-A Tosufloxacin tosylate and preparation method thereof 赤峰万泽药业股份有限公司 2022-04-19 CN claimed
CN-102531987-B (S) synthetic method of 3 amino-pyrrolidine dihydrochlorides SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2016-12-14 CN claimed
CN-102531987-A Synthesis method of (S)-3-amino pyrrolidine dihydrochloride SHANGHAI INST PHARM INDUSTRY 2012-07-04 CN claimed
CN-101168528-B Method for synthesizing 3-aminopyrrolidine and dihydrochloride thereof CHIFENG WANZE PHARMACY CO LTD 2011-10-05 CN claimed
CN-101168528-A Method for synthesizing 3-aminopyrrolidine and dihydrochloride thereof CHIFENG WANZE PHARMACY CO LTD (CN) 2008-04-30 CN claimed
CN-1331852-C Synthesis method of N-substituted-3-amidopyrrolidine and its bihydrochlorate UNIV ZHEJIANG (CN) 2007-08-15 CN claimed
CN-1733720-A Synthesis method of N-substituted-3-amidopyrrolidine and its bihydrochlorate UNIV ZHEJIANG (CN) 2006-02-15 CN claimed
EP-0945496-B1 Ink compositions and multicolor thermal ink jet printing process for the production of high quality images XEROX CORP (US) 2003-11-12 EP claimed
EP-0945496-A1 Ink compositions and multicolor thermal ink jet printing process for the production of high quality images Xerox Corporation (US) 1999-09-29 EP claimed
US-5958121-A SET OF INKS COMPRISING FIRST AQUEOUS INK CONSISTING OF ANIONIC COLORANT, SECOND AQUEOUS INK CONTAINING AMMONIUM SALT, WHEREIN FIRST COLORANT IS IMMOBILIZED ON SUBSTRATE BY INTERACTION WITH AMMONIUM SALT, REDUCING INTERCOLOR BLEED XEROX CORPORATION (US) 1999-09-28 US claimed
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
US-12472543-B2 Waste disposal system and waste receiver for receiving and disposing of pharmaceutical waste material STRYKER CORPORATION (US) 2025-11-18 US disclosed
US-12434282-B2 Pharmaceutical waste system STRYKER CORPORATION (US) 2025-10-07 US disclosed
US-20250268679-A1 Waster Receiver For Receiving A Pharmaceutical Waste Material STRYKER CORPORATION (US) 2025-08-28 US disclosed
US-4704459-A VILSMEIER REAGENT TOYAMA CHEMICAL CO., LTD. (JP) 1987-11-03 US disclosed
EP-0218249-A2 Process for the production of 3-aminopyrrolidines Tokyo Kasei Kogyo Co., Ltd (JP) 1987-04-15 EP disclosed
CN-86100879-A Novel process for preparing 1-substituted aryl-1, 4-dihydro-4-oxo-1, 8-naphthyridine derivatives and intermediates thereof 1986-12-17 CN disclosed
CN-85103150-A Process for producing antibacterial agent containing 1, 4-dihydro-4-oxo-1, 8-naphthyridine derivative and salt thereof 1986-10-22 CN disclosed